Pfizer Inc (MIL:1PFE)
€ 24.625 -0.215 (-0.87%) Market Cap: 139.23 Bil Enterprise Value: 192.39 Bil PE Ratio: 35.39 PB Ratio: 1.61 GF Score: 64/100

Pfizer Inc Conference Call to Review DMD Data Presentation at ASGCT Annual Meeting Transcript

May 15, 2020 / 02:00PM GMT

May 15, 2020 / 02:00PM GMT
Presentation at ASGCT Annual Meeting
May 15, 2020 / 02:00PM GMT

=====================
Corporate Participants
=====================
* Charles E. Triano
Pfizer Inc. - SVP of IR
* Michael Binks
Pfizer Inc. - Vice President, Rare Disease Clinical Research
* Mikael Dolsten
Pfizer Inc. - Chief Scientific Officer and President of Worldwide Research, Development & Medical
* Seng Cheng
Pfizer Inc. - Chief Scientific Officer and Senior Vice President, Rare Disease

=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc, Research Division - Global Head of Healthcare Research and MD
* Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst
* David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
* Terence C. Flynn
Goldman Sachs Group Inc., Research Division - MD
* Umer Raffat
Evercore ISI Institutional

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot